Opinion|Videos|February 17, 2025
The Role of Private Label Agreements in Enhancing Access to Biosimilars
Panelists discuss how private label agreements facilitate biosimilar market entry by allowing manufacturers to collaborate on branding, distribution, and market access, ultimately expanding treatment options and potentially reducing health care costs.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- What is the role of private label agreements and how can they enhance access to biosimilars?
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
ACP Names Semaglutide, Tirzepatide as First-Line Pharmacotherapy for Obesity
2
Hans Lee, MD, Discusses “Off-the-Shelf” Solution for Rare Blood Disorder With No Approved Therapies
3
CMS Proposes Permanent Rules for Medicare Drug Price Negotiation
4
AI Billing, GLP-1s Among Forces Driving 9% Health Cost Spike
5